Cho-Chung YS - Search Results

1

Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth.

Park YG, Nesterova M, Agrawal S, Cho-Chung YS. Park YG, et al. J Biol Chem. 1999 Jan 15;274(3):1573-80. doi: 10.1074/jbc.274.3.1573. J Biol Chem. 1999. PMID: 9880535 Free article.

2

Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy.

Cho-Chung YS, Nesterova M, Becker KG, Srivastava R, Park YG, Lee YN, Cho YS, Kim MK, Neary C, Cheadle C. Cho-Chung YS, et al. Ann N Y Acad Sci. 2002 Jun;968:22-36. doi: 10.1111/j.1749-6632.2002.tb04324.x. Ann N Y Acad Sci. 2002. PMID: 12119265 Review.

3

Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.

Nesterova MV, Cho-Chung YS. Nesterova MV, et al. Clin Cancer Res. 2004 Jul 1;10(13):4568-77. doi: 10.1158/1078-0432.CCR-03-0436. Clin Cancer Res. 2004. PMID: 15240549

4

A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth.

Nesterova M, Cho-Chung YS. Nesterova M, et al. Nat Med. 1995 Jun;1(6):528-33. doi: 10.1038/nm0695-528. Nat Med. 1995. PMID: 7585118

5

Antisense depletion of RIalpha subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells.

Srivastava RK, Srivastava AR, Park YG, Agrawal S, Cho-Chung YS. Srivastava RK, et al. Breast Cancer Res Treat. 1998 May;49(2):97-107. doi: 10.1023/a:1005905723550. Breast Cancer Res Treat. 1998. PMID: 9696392

6

CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.

Lee YN, Park YG, Choi YH, Cho YS, Cho-Chung YS. Lee YN, et al. Biochemistry. 2000 Apr 25;39(16):4863-8. doi: 10.1021/bi992272o. Biochemistry. 2000. PMID: 10769144

7

Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.

Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS. Nesterova M, et al. Clin Cancer Res. 2000 Sep;6(9):3434-41. Clin Cancer Res. 2000. PMID: 10999726

8

CRE-decoy oligonucleotide-inhibition of gene expression and tumor growth.

Cho-Chung YS, Park YG, Nesterova M, Lee YN, Cho YS. Cho-Chung YS, et al. Mol Cell Biochem. 2000 Sep;212(1-2):29-34. Mol Cell Biochem. 2000. PMID: 11108133 Review.

9

Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.

Nesterova M, Cho-Chung YS. Nesterova M, et al. Antisense Nucleic Acid Drug Dev. 2000 Dec;10(6):423-33. doi: 10.1089/oli.1.2000.10.423. Antisense Nucleic Acid Drug Dev. 2000. PMID: 11198926

10

Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.

Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS. Cho YS, et al. Clin Cancer Res. 2002 Feb;8(2):607-14. Clin Cancer Res. 2002. PMID: 11839683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters